3200 Travis, 3rd Floor
Houston, TX 77006
713-529-0025
713-751-0412
|
Galveston Office
409-762-9090
Veozah Lawsuit
Our law firm is currently evaluating claims for patients who were diagnosed with liver damage or liver tumors after taking the menopause medication Veozah. Recent FDA studies have found the drug Veozah could lead to liver damage or tumors after only 40 days of use by the patients.
If you or a loved one has been diagnosed with liver damage after taking the drug Veozah, please contact our law firm today as you may be entitled to financial compensation. Contact the Steinberg law firm now for a free consultation.
FDA Warnings – Veozah (fezolinetant)
The U.S. Food and Drug Administration (FDA) has issued a black-box warning, its most stringent alert, for Veozah, a medication used to manage menopausal hot flashes. According to the FDA, patients taking Veozah may require more frequent blood tests to monitor for potential liver-related issues.
In addition to liver-related issues, Veozah may also increase the risk of stroke and blood clots. This new warning serves as a reminder for healthcare providers to carefully assess each patient’s individual risk factors before prescribing Veozah.
Veozah Side Effects
If you are currently taking Veozah and notice any of the following symptoms, the FDA advises discontinuing the medication immediately and consulting a healthcare professional:
- Nausea
- Vomiting
- Persistent or unusual itching
- Pale or light-colored stools
- Dark-colored urine
- Unusual fatigue or excessive tiredness
- Yellowing of the skin or eyes (jaundice)
- Abdominal swelling
- Pain in the upper right side of the abdomen
Prompt medical attention is recommended to address these potential concerns.
Please contact our law firm today as you may be entitled to financial compensation.
FDA Warnings – What you need to know.
-
The FDA has issued an updated warning for Veozah, highlighting an increased risk of liver injury. Here’s what you need to know:
- New Guidelines for Starting and Stopping the Medication: The updated warning now includes specific instructions on when treatment can begin and when it should be discontinued if risks arise.
- Enhanced Monitoring Requirements: While baseline bloodwork was already recommended, the FDA now requires monthly liver enzyme tests during the first two months of treatment.
- Continued Testing Protocols: Routine testing will also continue at months 3, 6, and 9 after starting Veozah.
If you have been prescribed Veozah, it is crucial to follow your healthcare provider’s instructions and attend all recommended appointments for monitoring and testing. Any changes in your health or side effects should be reported immediately.
ACT NOW
If you or a loved one has been diagnosed with liver damage or received a liver tumor diagnosis after taking the drug Veozah, please contact our law firm today as you may be entitled to financial compensation. Contact the Steinberg law firm now for a free consultation.